Anticoagulation poses unique challenges for women of reproductive age. Clinicians
prescribing anticoagulants must counsel patients on issues ranging from menstruation and …

Preliminary data and clinical experience have suggested an increased risk of abnormal
uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but solid …

Pharmacovigilance is defined by the World Health Organization as “the science and
activities relating to the detection, assessment, understanding and prevention of adverse …

Aims Clinical trials have found differences in bleeding locations between direct oral
anticoagulants (DOAC) and vitamin K antagonists (VKA). The present study was performed …

Purpose Our objective is to describe how the US Food and Drug Administration (FDA)'s
Sentinel System implements best practices to ensure trust in drug safety studies using real …

Background Although abnormal uterine bleeding is a known adverse effect of anticoagulant
drugs, true rates have not been widely studied. Society-backed recommendations and …

Introduction Little is known about the clinical characteristics of women at increased risk for
abnormal uterine bleeding (UB) during anticoagulation for venous thromboembolism (VTE) …

口服抗凝治疗增加易栓症患者异常子宫出血的发生风险:一项单中心回顾性研究 邮件订阅 RSS
首页 关于本刊 1.期刊介绍 2.编委会 3.主编风采 投稿指南 1.投稿须知 2.版权转让协议 3.研究报告 …

Актуальность: Несмотря на прогресс в медицине маточные кровотечения остаются
общеизвестной медицинской проблемой. Аномальные маточные кровотечения …

Аннотация Аномальные маточные кровотечения, широко распространенные в когорте
женщин фертильного возраста, несомненно, являются чрезвычайно важным …